1. Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients
    Ahmed Talaat Hanbal et al, 2024, Journal of the Egyptian National Cancer Institute CrossRef